OZEM vs. PSCH ETF Comparison
Comparison of Roundhill GLP-1 & Weight Loss ETF (OZEM) to PowerShares S&P SmallCap Health Care Portfolio (PSCH)
OZEM
Roundhill GLP-1 & Weight Loss ETF
OZEM Description
OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.
Grade (RS Rating)
Last Trade
$27.12
Average Daily Volume
74,426
7
PSCH
PowerShares S&P SmallCap Health Care Portfolio
PSCH Description
The PowerShares S&P SmallCap Health Care Portfolio (Fund) is based on the S&P SmallCap 600® Capped Health Care Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to measure the overall performance of common stocks in the health care sector. Included are healthcare companies principally engaged in the business of providing healthcare-related products and services, including biotechnology, pharmaceuticals, medical technology and supplies, and facilities. The Index is a subset of the S&P SmallCap 600® Index, which is a float-adjusted, market-capitalization-weighted index reflecting the US small-cap market. The Fund and the Index are rebalanced and reconstituted quarterly.Grade (RS Rating)
Last Trade
$42.24
Average Daily Volume
14,569
64
Performance
| Period | OZEM | PSCH |
|---|---|---|
| 30 Days | 4.03% | -2.97% |
| 60 Days | -0.76% | |
| 90 Days | -0.50% | |
| 12 Months | -1.21% |
0 Overlapping Holdings
| Symbol | Grade | Weight in OZEM | Weight in PSCH | Overlap |
|---|
OZEM Underweight 64 Positions Relative to PSCH
| Symbol | Grade | Weight | |
|---|---|---|---|
| ENSG | B | -5.59% | |
| GKOS | A | -4.82% | |
| OGN | C | -4.35% | |
| MMSI | B | -3.95% | |
| KRYS | B | -3.71% | |
| ALKS | C | -3.41% | |
| RDNT | B | -3.17% | |
| ITGR | C | -3.15% | |
| SEM | A | -2.96% | |
| PBH | C | -2.82% | |
| CORT | C | -2.37% | |
| TNDM | C | -2.15% | |
| ICUI | B | -1.97% | |
| NARI | C | -1.97% | |
| CRVL | B | -1.87% | |
| MYGN | B | -1.83% | |
| STAA | B | -1.83% | |
| VCEL | C | -1.82% | |
| CNMD | D | -1.7% | |
| AMN | F | -1.67% | |
| FTRE | D | -1.66% | |
| IART | C | -1.61% | |
| PINC | F | -1.59% | |
| ADUS | B | -1.58% | |
| PDCO | F | -1.56% | |
| UFPT | A | -1.47% | |
| PRVA | D | -1.4% | |
| CPRX | D | -1.39% | |
| ASTH | C | -1.39% | |
| NEO | D | -1.39% | |
| LMAT | A | -1.34% | |
| AMPH | F | -1.25% | |
| CERT | D | -1.23% | |
| SUPN | F | -1.2% | |
| NHC | A | -1.19% | |
| DVAX | D | -1.18% | |
| USPH | F | -1.17% | |
| LGND | B | -1.08% | |
| PCRX | F | -1.05% | |
| OMCL | F | -0.99% | |
| XNCR | F | -0.98% | |
| OMI | F | -0.88% | |
| COLL | C | -0.85% | |
| SDGR | F | -0.84% | |
| ANIP | D | -0.82% | |
| HRMY | B | -0.81% | |
| INVA | B | -0.73% | |
| AVNS | F | -0.72% | |
| IRWD | F | -0.71% | |
| RCUS | F | -0.68% | |
| VIR | F | -0.65% | |
| BLFS | C | -0.64% | |
| SLP | F | -0.63% | |
| AHCO | D | -0.63% | |
| EMBC | F | -0.58% | |
| HSTM | C | -0.55% | |
| MD | F | -0.52% | |
| VREX | F | -0.48% | |
| RGNX | F | -0.43% | |
| CTKB | D | -0.42% | |
| CCRN | F | -0.38% | |
| MLAB | D | -0.37% | |
| FLGT | F | -0.34% | |
| PAHC | C | -0.29% |
OZEM: Top Represented Industries & Keywords
PSCH: Top Represented Industries & Keywords
Compare ETFs
